February 2012 Drug Update Information - Pharmacy Benefits ...

More documents

Recommendations

Info

Article link: http://health.usnews.com/health-news/family- health/pain/articles/2012/01/05/drugeases-gout-flare-ups-in-some-patients-study Source website: http: ://www.usnews.com/ ADHD Drug Shortage Pushes Parents to Seek Substitutes January 6, 2012 But experts say medication switches must be done carefully. If the current shortage of some drugs used to treat attention-deficit/hyperactivity disorder (ADHD) has left you searching for something else for your child to take, experts suggest youu choose a substitute carefully because the effects of these medications can vary widely. Article link: http://consumer.healthday.com/Article.asp?AID=660423 Source website: http: ://consumer. healthday.com/ Boehringer’s Pradaxa Increases Risk of Heart Attack, Study Shows January 9, 2012 Boehringer Ingelheim’s anti-coagulant Pradaxa increasess a patient’s risk of heart attack or severe chest pain, according to a review of studies conducted onn the drug. An analysis of seven clinical trials found that it was “significantly associated with a higher risk” of heart attacks and acute coronary syndrome, or ACS, a designation that includes heart attacks and chest pain, researchers wrote in a report published today in the Archives of Internal Medicine. Article link: http://www.bloomberg.com/news/2012-01-09/boehringer-s-pradaxa-increases-risk- some investors on Monday. Article link: http://uk.reuters.com/article/2012/01/09/uk-gsk-relovair- idUKTRE8080C120120109 Source website: http: ://uk.reuters.com/ Nicotine Gum and Skin Patch Face New Doubt January 9, 2012 ofheart-attack-study-shows.html website: http: ://www.bloomberg.com/ Aspirin guidelines need overhaul, researchers say Source January 9, 2012 Healthy people shouldn't be taking aspirin to prevent heart disease, researchers say in a new report that casts doubt on recommendations from U.S. health officials. Article link: http://www.reuters.com/article/2012/01/09/us-aspirin- benefitsidUSTRE80825720120109 Source website: http: ://www.reuters.com/ GSK to file lung drug despite disappointin ng data January 9, 2012 GlaxoSmithKline will push ahead with filing its key new lung drug Relovair for regulatory approval in mid-2012, despite releasing a mixed batch off clinical trial results that disappointed The nicotine gum and patches that millions of smokers use to help kick their habit have no lasting benefit and may backfire in some cases, accordingg to the most rigorous long-term study to date of so-called nicotine replacement therapy. Article link: http://www.nytimes.com/2012/01/10/health/study-finds-nicotine-gum-and- patchesdont-help-smokers-quit.html Source website: http: ://www.nytimes.com/ 14
Statins raise risk of Type 2 diabetes in older women, study finds January 10, 2012 Post-menopausal women who take statins to ward off heart attacks are more likely to develop Type 2 diabetes than those who do not, research indicates. Older women who take statin medications to ward off heart attacks are more likely to develop Type 2 diabetes than those who do not take the widely used cholesterol-lowering drugs, a study has found. Article link: http://www.latimes. com/news/science/la-he-statins-diabetes-20120110,0,1285531. story?track=rss Source website: http: ://www.latimes.com/ Roche’s Zelboraf for Melanoma Spurs Other Skin Cancer’s Growth, Study Says January 12, 2012 Roche’s melanoma drug Zelboraf speeds growth of another type of skin cancer, researchers said today in a study underscoring the need to testt the medicine in combination with a second treatment. Scientists at the Institute of Cancer Research analyzed DNA in 21 tissue samples from Zelboraf patients who developedd cutaneous squamous-ce ell carcinoma. About 60 percent of the samples had one of two known cancer-causing gene mutations not targeted by the drug, they said in an article published in the New England Journal of Medicine today. Article link: http://www.bloomberg.com/news/2012-01-18/roche-s-zelboraf-for-melanoma- spursother-skin-cancer-s-growth-study-says.html Source website: http: ://www.bloomberg.com/ Antidepressants While Pregnant Linked to Slight Risk of Lung Problem in Babies Jan 12, 2012 Study found women who took SSRIs a bit more likely too have infants with high blood pressure in the lungs. Women who use antidepressants called selective serotonin-reuptakee inhibitors such asProzac and Celexa during pregnancy run a slight risk of having an infant with high blood pressure in the lungs, a new Swedish study finds. Article link: http://consumer.healthday.com/Article.asp?AID=660699 Source website: http: ://consumer. healthday.com/ DNA Damage From Chemo May Help Spur Leukemia's Return Jan. 12, 2012 The treatment can achieve acute myeloid leukemia remission, but better options needed, experts Say. The chemotherapy used to treat a form of adult leukemia sets a trap that can result in the return of the disease within years, a new study suggests. Article link: http://consumer.healthday.com/Article.asp?AID=660653 Source website: http: ://consumer. healthday.com/ Diabetes Drug Helps All Shed Pounds January 12, 2012 One class of diabetes drugs -- the glucagon-like peptide-researchers found. receptor (GLP-1) agonists -- can help diabetics and nondiabetics alike lose weight, Article link: http://www.medpagetoday.com/ /PrimaryCare/Diabetes/30638 Source website: http: ://www.medpagetoday.com/ Antidepressant Use Linked to Increased Pulmonary Hypertension Risk in Infants January 13, 2012 A study published in the British Medical Journal this week provides stronger evidence that taking some antidepressants during pregnancy doubles the risk of a baby developing pulmonary 15
Page 1 and 2: February 2012 Drug Information Upda
Page 3 and 4: GENERIC DRUG NAME GENERIC APPROVAL
Page 5 and 6: CICLOPIROX/ TOPICAL PEDIPIROX-4 New
Page 7 and 8: [Posted 01/09/2012] ISSUE: Novartis
Page 9 and 10: Studies Article Link: http://www.fd
Page 11 and 12: the use of XARELTO® (rivaroxaban),
Page 13: acteria. The Food and Drug Administ
Page 17 and 18: The Million Women Study, a U.K. pro
Page 19 and 20: Azithromycin 250 mg tablets, 1 card
Page 21 and 22: RECALLING FIRM/MANUFACTURE Recallin
Page 23 and 24: Recalling Firm: Pfizer Us Pharmaceu
Page 25 and 26: 250 mg, 100 count (NDC 00591-3969-0
Page 27 and 28: Sandoz states the shortage is due t
Page 29 and 30: 5 mL ampule (NDC 10019-0033-72) 20
Page 31 and 32: Article Link: http://www.ashp.org/D
Page 33 and 34: Lidocaine 2% (with epinephrine 1:10
Page 35 and 36: Source: http://www.a ashp.org Halop
Page 37 and 38: ecome unavailable for an extended t
Page 39 and 40: American Regent resumed manufacturi
Page 41 and 42: Trandate tablets, Prometheus 100 mg
Page 43 and 44: Article link: http://www.ashp.org/D
Page 45 and 46: Bedford Laboratories has multiple p
Page 47 and 48: Thiothixene capsules, Mylan 2 mg ca
Page 49 and 50: 20 mL vials (NDC 10019-0905-03) - d
Page 51 and 52: 500 mg extended release, 500 count
Page 53 and 54: 1 mg/mL, 4 mL vial (NDC 25021-0781-
Page 55 and 56: West-Ward states the shortage is du
Page 57 and 58: 150 mL bottle (NDC 63304-0954-02) C

February 2012 Drug Update Information - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?